REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrum Specjalistyczne Biomed Borowscy sp. j. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Lessors of Real Estate | Offices of Physicians
Full name: Centrum Specjalistyczne Biomed Borowscy sp. j. Profile Updated: April 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Centrum Specjalistyczne Biomed Borowscy sp. j. is an enterprise based in Poland. Its main office is in Boleslawiec. The company operates in the Ambulatory Health Care Services sector. The company was established on June 25, 2014. There was a net sales revenue increase of 15.47% reported in Centrum Specjalistyczne Biomed Borowscy sp. j.’s latest financial highlights for 2024. Over the same period, its total assets grew by 76.25%. The net profit margin of Centrum Specjalistyczne Biomed Borowscy sp. j. decreased by 1.71% in 2024.

Headquarters
Ul. Piaskowa 15
Boleslawiec; Dolnoslaskie; Postal Code: 59-700

Contact Details: Purchase the Centrum Specjalistyczne Biomed Borowscy sp. j. report to view the information.

Basic Information
Financial Auditors:
Purchase the Centrum Specjalistyczne Biomed Borowscy sp. j. report to view the information.
Incorporation Date:
June 25, 2014
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Centrum Specjalistyczne Biomed Borowscy sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.47%
Total operating revenue
15.31%
Operating profit (EBIT)
8.16%
EBITDA
10.43%
Net Profit (Loss) for the Period
8.16%
Total assets
76.25%
Total equity
101.26%
Operating Profit Margin (ROS)
-1.71%
Net Profit Margin
-1.71%
Return on Equity (ROE)
-43.69%
Debt to Equity Ratio
-3.7%
Quick Ratio
1.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?